Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Blanck

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
International Immunology|April 26, 2024
High-throughput quantitative assessments of the chemical complementarity of celiac disease-related IGH CDR3s and a gliadin epitopeRahul Jain, Max Bressler, Andrea Chobrutskiy, et al.
Proteomics. Clinical Applications|February 22, 2019
Matrix-Metalloprotease Resistant Mucin-16 (MUC16) Peptide Mutants Represent a Worse Lung Adenocarcinoma OutcomeJay S Patel, Blake M Callahan, Boris I Chobrutskiy, et al.
Breast Cancer Research and Treatment|November 12, 2020
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancerAndrea Chobrutskiy, Boris I Chobrutskiy, Saif Zaman, et al.
Cell Cycle (Georgetown, Tex.)|April 14, 2016
Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approachMohammad D Samy, John M Yavorski, James A Mauro, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 15, 2017
Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdensYaping N Tu, Wei Lue Tong, Timothy J Fawcett, et al.
International Journal of Cancer|October 20, 2017
Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoirBlake M Callahan, Jay S Patel, Timothy J Fawcett, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|January 23, 2018
Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ RecombinationsYaping N Tu, Wei Lue Tong, John M Yavorski, et al.
Human Immunology|January 27, 2019
T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival ratesAndrea M Roca, Boris I Chobrutskiy, Blake M Callahan, et al.
Archives of Gerontology and Geriatrics|March 11, 2025
Association of the HLA-DQB1*02 allele with lower tauopathy in Alzheimer's diseaseTaha I Huda, Timothy J Fawcett, Anthony J Green, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2018
T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancerBoris I Chobrutskiy, Saif Zaman, Andrea Diviney, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
International Immunology|April 26, 2024
High-throughput quantitative assessments of the chemical complementarity of celiac disease-related IGH CDR3s and a gliadin epitopeRahul Jain, Max Bressler, Andrea Chobrutskiy, et al.
Proteomics. Clinical Applications|February 22, 2019
Matrix-Metalloprotease Resistant Mucin-16 (MUC16) Peptide Mutants Represent a Worse Lung Adenocarcinoma OutcomeJay S Patel, Blake M Callahan, Boris I Chobrutskiy, et al.
Breast Cancer Research and Treatment|November 12, 2020
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancerAndrea Chobrutskiy, Boris I Chobrutskiy, Saif Zaman, et al.
Cell Cycle (Georgetown, Tex.)|April 14, 2016
Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approachMohammad D Samy, John M Yavorski, James A Mauro, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 15, 2017
Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdensYaping N Tu, Wei Lue Tong, Timothy J Fawcett, et al.
International Journal of Cancer|October 20, 2017
Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoirBlake M Callahan, Jay S Patel, Timothy J Fawcett, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|January 23, 2018
Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ RecombinationsYaping N Tu, Wei Lue Tong, John M Yavorski, et al.
Human Immunology|January 27, 2019
T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival ratesAndrea M Roca, Boris I Chobrutskiy, Blake M Callahan, et al.
Archives of Gerontology and Geriatrics|March 11, 2025
Association of the HLA-DQB1*02 allele with lower tauopathy in Alzheimer's diseaseTaha I Huda, Timothy J Fawcett, Anthony J Green, et al.
Journal of Cancer Research and Clinical Oncology|December 13, 2018
T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancerBoris I Chobrutskiy, Saif Zaman, Andrea Diviney, et al.
Pageof 15